NuVasive - Stock Price History | NUVA

Historical daily share price chart and data for NuVasive since 2020 adjusted for splits. The latest closing stock price for NuVasive as of February 19, 2020 is 79.40.
  • The all-time high NuVasive stock closing price was 81.13 on January 14, 2020.
  • The NuVasive 52-week high stock price is 81.91, which is 3.2% above the current share price.
  • The NuVasive 52-week low stock price is 52.69, which is 33.6% below the current share price.
  • The average NuVasive stock price for the last 52 weeks is 65.21.
NuVasive Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 61.4244 48.4700 77.7000 44.5300 77.3400 56.05%
2018 56.7480 61.2800 71.4100 46.0300 49.5600 -15.27%
2017 67.5279 66.1600 81.1100 50.5800 58.4900 -13.17%
2016 57.0062 52.2500 68.3800 38.9100 67.3600 24.49%
2015 49.0110 46.6400 55.6900 41.5500 54.1100 14.74%
2014 37.0759 31.8400 48.1000 31.8400 47.1600 45.87%
2013 23.7837 16.0300 33.5200 15.7600 32.3300 109.12%
2012 17.9232 12.5800 25.7600 11.3500 15.4600 22.80%
2011 24.4330 26.6200 34.6500 11.0700 12.5900 -50.92%
2010 34.0846 32.8000 46.4200 22.2500 25.6500 -19.79%
2009 36.8994 34.8200 44.6000 24.7400 31.9800 -7.71%
2008 41.9862 38.7800 57.5000 30.3400 34.6500 -12.32%
2007 30.0675 22.7200 44.1300 22.0000 39.5200 71.08%
2006 19.7345 18.3100 25.0500 15.3800 23.1000 27.62%
2005 15.7323 10.0800 20.1300 10.0800 18.1000 76.59%
2004 10.1629 11.4000 11.7400 8.9000 10.2500 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.093B $1.102B
NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $157.180B 27.43
Medtronic (MDT) Ireland $151.007B 20.30
Stryker (SYK) United States $83.129B 26.87
Boston Scientific (BSX) United States $58.764B 26.52
Baxter (BAX) United States $47.083B 28.55
EssilorLuxottica Societe Anonyme (ESLOY) France $33.039B 0.00
Zimmer Biomet Holdings (ZBH) United States $32.755B 20.24
Lonza Group Ag (LZAGY) Switzerland $31.832B 0.00
Coloplast (CLPBY) Denmark $30.521B 47.10
Terumo (TRUMY) Japan $26.424B 32.98
ResMed (RMD) United States $25.279B 43.92
Smith & Nephew SNATS (SNN) United Kingdom $20.980B 0.00
Sunny Optical Technology (SNPTF) China $18.537B 0.00
Insulet (PODD) United States $13.123B 624.32
Bio-Rad Laboratories (BIO) United States $12.197B 56.99
Perrigo (PRGO) Ireland $8.024B 14.96
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Canopy Growth (CGC) Canada $7.665B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
Hill-Rom Holdings (HRC) United States $7.297B 20.99
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Haemonetics (HAE) United States $6.055B 37.27
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Envista Holdings (NVST) United States $4.515B 0.00
ICU Medical (ICUI) United States $4.409B 28.74
GW Pharmaceuticals (GWPH) United Kingdom $3.835B 0.00
Neogen (NEOG) United States $3.815B 63.48
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.657B 0.00
Quidel (QDEL) United States $3.345B 29.36
Agios Pharmaceuticals (AGIO) United States $3.137B 0.00
National Vision Holdings (EYE) United States $2.802B 63.25
Aurora Cannabis (ACB) Canada $1.917B 0.00
AtriCure (ATRC) United States $1.707B 0.00
TG Therapeutics (TGTX) United States $1.579B 0.00
Cardiovascular Systems (CSII) United States $1.536B 0.00
InMode (INMD) Israel $1.301B 0.00
NanoString Technologies (NSTG) United States $1.180B 0.00
Aphria (APHA) $1.127B 0.00
Phibro Animal Health (PAHC) United States $1.093B 21.62
VAREX IMAGING (VREX) United States $0.984B 20.45
PetIQ (PETQ) United States $0.960B 23.43
Quanterix (QTRX) United States $0.778B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.727B 27.86
Omeros (OMER) United States $0.674B 0.00
Lantheus Holdings (LNTH) United States $0.650B 16.23
LeMaitre Vascular (LMAT) United States $0.605B 34.41
Surmodics (SRDX) United States $0.523B 60.17
MacroGenics (MGNX) United States $0.514B 0.00
Organigram Holdings (OGI) Canada $0.438B 0.00
HEXO (HEXO) $0.418B 0.00
OraSure Technologies (OSUR) United States $0.406B 24.33
Owens & Minor (OMI) United States $0.404B 14.93
Utah Medical Products (UTMD) United States $0.351B 24.93
Meridian Bioscience (VIVO) United States $0.334B 13.43
Zynex (ZYXI) United States $0.333B 37.70
BioLife Solutions (BLFS) United States $0.318B 129.50
Female Health (VERU) United States $0.286B 0.00
Bovie Medical (APYX) United States $0.259B 0.00
Repro-Med Systems (KRMD) United States $0.237B 0.00
InfuSystems Holdings (INFU) United States $0.220B 1110.00
Vapotherm (VAPO) United States $0.219B 0.00
Viemed Healthcare (VMD) United States $0.209B 22.00
United Health Products (UEEC) United States $0.192B 0.00
Rockwell Medical (RMTI) United States $0.185B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.178B 0.00
Liberty Health Sciences (LHSIF) Canada $0.178B 0.00
Cytosorbents (CTSO) United States $0.175B 0.00
Fonar (FONR) United States $0.131B 9.57
Green Organic Dutchman Holdings (TGODF) Canada $0.128B 0.00
Chimerix (CMRX) United States $0.108B 0.00
MRI Interventions (CLPT) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Surface Oncology (SURF) United States $0.086B 0.00
United-Guardian (UG) United States $0.081B 20.62
MTech Acquisition (KERN) United States $0.075B 0.00
Nephros (NEPH) United States $0.072B 0.00
Chembio Diagnostics (CEMI) United States $0.071B 0.00
FSD PHARMA INC (HUGE) Canada $0.045B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
NF Energy Saving (BIMI) China $0.031B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.007B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Myomo (MYO) United States $0.003B 0.00
Valeritas Holdings (VLRX) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00